期刊
ORGANIC LETTERS
卷 22, 期 4, 页码 1448-1452出版社
AMER CHEMICAL SOC
DOI: 10.1021/acs.orglett.0c00042
关键词
-
资金
- National Science Foundation [CHE-1565788]
- National Institutes of Health [AI146485, AI144196, AI142040, CA213201]
An asymmetric synthesis of two analogues of SL0101 (1) has been achieved. The effort is aimed at the discovery of inhibitors of the p90 ribosomal S6 kinase (RSK) with improved bioavailability. The route relies upon the use of the Taylor catalyst to regioselectively install C-3 '' acetyl or carbamate functionality. This study led to the identification of a third-generation analogue of SL0101 with a C-4 '' n-Pr-carbamate and a C-3 '' acetate with improved RSK inhibitory activity.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据